HHS Issues Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances
DO
By Daniel Okafor · Regulatory Correspondent
Oct 29 14:09 ETSource: JD Supra
From the source
Read at jdsupra.comHHS Issues Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances
